HR 2071
117th Congress
House
Health
Health care costs and insurance
Inflation and prices
Medicare
Prescription drugs
Public contracts and procurement
Medicare Prescription Drug Price Negotiation Act of 2021
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 19, 2021
Referred to the Subcommittee on Health.
Mar 18, 2021
Referred to the Subcommittee on Health.
Mar 18, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 18, 2021
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Medicare Prescription Drug Price Negotiation Act of 2021
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
What's happening now
Referred to the Subcommittee on Health.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
4
Cite this page
U.S. Congress. (2026). H.R. 2071: Medicare Prescription Drug Price Negotiation Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-2071/
"H.R. 2071: Medicare Prescription Drug Price Negotiation Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-2071/.
H.R. 2071, 117th Cong. (2026), https://openamerica.io/bill/117-HR-2071/.
[H.R. 2071: Medicare Prescription Drug Price Negotiation Act of 2021](https://openamerica.io/bill/117-HR-2071/)